Skip to main content

rituximab (MabThera®)

 

Appraisal in progress

Indication

Status: In progress

For the treatment of patients with moderate to severe pemphigus vulgaris. 

Medicine details

Medicine name rituximab (MabThera®)
Formulation 100mg concentrate for solution for infusion, 500mg concentrate for solution for infusion
Reference number 3192
Indication

As above

Company Roche Products Ltd
BNF chapter Skin
Submission type Directed
Status In progress
NMG meeting date 06/07/2022
AWMSG meeting date 14/09/2022
Date of issue TBC
Follow AWTTC: